KIAA1107 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.608200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.345600E-01
Normal-vs-Stage2
9.064800E-01
Normal-vs-Stage3
3.102200E-02
Normal-vs-Stage4
3.867200E-01
Stage1-vs-Stage2
7.933700E-02
Stage1-vs-Stage3
1.093830E-02
Stage1-vs-Stage4
9.614200E-01
Stage2-vs-Stage3
7.637200E-04
Stage2-vs-Stage4
1.725770E-01
Stage3-vs-Stage4
9.293500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.810000E-01
Normal-vs-AfricanAmerican
8.287400E-01
Normal-vs-Asian
9.193600E-01
Caucasian-vs-AfricanAmerican
8.556600E-01
Caucasian-vs-Asian
9.657800E-01
AfricanAmerican-vs-Asian
8.821600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.777400E-01
Normal-vs-Female
7.503600E-01
Male-vs-Female
2.168000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.934450E-01
Normal-vs-Age(41-60Yrs)
5.910000E-01
Normal-vs-Age(61-80Yrs)
9.918000E-01
Normal-vs-Age(81-100Yrs)
8.061800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.366800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.555000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.283000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.767800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.560950E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.704600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.694800E-01
Normal-vs-Daily Drinker
8.427600E-01
Normal-vs-Weekly Drinker
4.396400E-01
Normal-vs-Occasional Drinker
4.330600E-01
Normal-vs-Social Drinker
6.061200E-01
Non Drinker-vs-Daily Drinker
4.384600E-01
Non Drinker-vs-Weekly Drinker
3.567200E-01
Non Drinker-vs-Occasional Drinker
5.605500E-02
Non Drinker-vs-Social Drinker
1.485980E-01
Daily Drinker-vs-Weekly Drinker
1.538440E-01
Daily Drinker-vs-Occasional Drinker
3.209800E-01
Daily Drinker-vs-Social Drinker
4.895000E-01
Weekly Drinker-vs-Occasional Drinker
1.317700E-02
Weekly Drinker-vs-Social Drinker
6.165600E-02
Occasional Drinker-vs-Social Drinker
8.864400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.169800E-02
Normal-vs-Grade 2
3.465700E-02
Normal-vs-Grade 3
9.958400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.040400E-01
Grade 1-vs-Grade 3
4.748600E-01
Grade 1-vs-Grade 4
5.169800E-02
Grade 2-vs-Grade 3
4.484200E-01
Grade 2-vs-Grade 4
3.465700E-02
Grade 3-vs-Grade 4
9.958400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.511000E-01
Normal-vs-NonDiabetic
8.482800E-01
Diabetic-vs-NonDiabetic
1.236240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.396800E-01
Normal-vs-NoPancreatitis
9.486000E-01
Pancreatitis-vs-NoPancreatitis
7.586200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.618600E-01
Normal-vs-N1
8.739200E-01
N0-vs-N1
9.197800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.432800E-01
Normal-vs-TP53-NonMutant
5.918000E-01
TP53-Mutant-vs-TP53-NonMutant
9.579200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
